Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Arterra Bioscience SpA ( (IT:ARBS) ) has shared an update.
Arterra Bioscience S.p.A. reported a revenue of approximately 2.6 million euros as of June 30, 2025, marking a 12.8% increase from the same period in 2024. The growth was primarily driven by a 15% rise in sales of cosmetic raw materials. This positive trend supports the company’s confidence in achieving its planned goals, reflecting its strong market positioning and ongoing growth in the biotech industry.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is an Italian green biotech company specializing in research and development in biotechnology. Listed on the Euronext Growth Milan market since 2019, the company develops products and processes using living organisms for applications in cosmetics, agriculture, and nutraceuticals. Founded in 2004 by Gabriella Colucci, Arterra collaborates with various companies and research institutes, including a joint venture with Intercos S.p.A. for innovative skincare products.
Average Trading Volume: 13,062
Technical Sentiment Signal: Buy
Current Market Cap: €18.24M
See more data about ARBS stock on TipRanks’ Stock Analysis page.